People · Operator
Named in public records as an officer, director or promoter · active 2015–2020 · Other Health Care, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nuvaira, Inc. | — | Other Health Care | Series C | $177.8M | $191.7M | 2019 |
| TWELVE, Inc. | — | Other Technology | Series B | $88.8M | $1.1B | 2015 |
| Kona Medical, Inc. | — | Biotechnology | Series B | $61.6M | $396.9M | 2015 |
Christopher A. Shen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Christopher A. Shen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Henry A. Plain, Jr. | 2 | 7 |
| Hank Plain | 2 | 5 |
| Henry A. Plain | 2 | 5 |
| Mark Deem | 2 | 5 |
| Kirk Nielsen | 1 | 13 |
| Hanson S. Gifford III | 1 | 11 |
| Peter Cohn | 1 | 10 |
| Brian Halak | 1 | 10 |
| Immanuel Thangaraj | 1 | 6 |
| Michael A. Carusi | 1 | 6 |
| David Stassen | 1 | 5 |
| Hanson Gifford | 1 | 3 |
| Mike Carusi | 1 | 3 |
| MARK A. DEEM | 1 | 3 |
| Louis Cannon | 1 | 3 |
| DENNIS W. WAHR | 1 | 3 |
| Dave Stassen | 1 | 3 |
| Michael Gertner | 1 | 2 |
| GEOFFREY J DUYK | 1 | 2 |
| Mark S. Deem | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.